Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Iron supplementation and mortality in incident dialysis patients: an observational study.

Zitt E, Sturm G, Kronenberg F, Neyer U, Knoll F, Lhotta K, Weiss G.

PLoS One. 2014 Dec 2;9(12):e114144. doi: 10.1371/journal.pone.0114144. eCollection 2014.

2.

Darbepoetin alfa once every 2 weeks effectively maintained hemoglobin in dialysis patients in an observational study: Austrian cohort of ALTERNATE.

Pronai W, Neyer U, Barnas U, Wieser C, Jaeger C, Dekic D, Hemetsberger M, Rosenkranz AR.

Wien Med Wochenschr. 2014 Mar;164(5-6):109-19. doi: 10.1007/s10354-013-0256-7. Epub 2014 Jan 31.

PMID:
24482075
3.

Homoarginine and progression of chronic kidney disease: results from the Mild to Moderate Kidney Disease Study.

Drechsler C, Kollerits B, Meinitzer A, März W, Ritz E, König P, Neyer U, Pilz S, Wanner C, Kronenberg F; MMKD Study Group.

PLoS One. 2013 May 15;8(5):e63560. doi: 10.1371/journal.pone.0063560. Print 2013.

4.

Lipoprotein kinetics in male hemodialysis patients treated with atorvastatin.

Schwaiger JP, Nakada Y, Berberich R, Ikewaki K, Dieplinger B, Zitt E, Neyer U, Salmhofer H, Kronenberg F, Koenig P, Dieplinger H.

Clin J Am Soc Nephrol. 2013 Aug;8(8):1319-26. doi: 10.2215/CJN.10881012. Epub 2013 Apr 18.

5.

The MAINTAIN study--managing hemoglobin variability with darbepoetin alfa in dialysis patients experiencing a severe drop in hemoglobin.

Watschinger B, Salmhofer H, Horn S, Neyer U, Wiesinger T, Wiesholzer M, Erb H, Jaeger C, Hemetsberger M, Rosenkranz AR.

Wien Klin Wochenschr. 2013 Feb;125(3-4):71-82. doi: 10.1007/s00508-012-0311-1. Epub 2013 Jan 9.

PMID:
23299452
6.

Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease.

Zitt E, Sprenger-Mähr H, Knoll F, Neyer U, Lhotta K.

Vaccine. 2012 Jan 20;30(5):931-5. doi: 10.1016/j.vaccine.2011.11.086. Epub 2011 Dec 4.

PMID:
22142584
7.

Interaction of time-varying albumin and phosphorus on mortality in incident dialysis patients.

Zitt E, Lamina C, Sturm G, Knoll F, Lins F, Freistätter O, Kronenberg F, Lhotta K, Neyer U.

Clin J Am Soc Nephrol. 2011 Nov;6(11):2650-6. doi: 10.2215/CJN.03780411. Epub 2011 Sep 8.

8.

Coumarins and survival in incident dialysis patients.

Knoll F, Sturm G, Lamina C, Zitt E, Lins F, Freistätter O, Kronenberg F, Lhotta K, Neyer U.

Nephrol Dial Transplant. 2012 Jan;27(1):332-7. doi: 10.1093/ndt/gfr341. Epub 2011 Jul 18.

PMID:
21771750
9.

Association of HbA1c values with mortality and cardiovascular events in diabetic dialysis patients. The INVOR study and review of the literature.

Sturm G, Lamina C, Zitt E, Lhotta K, Haider F, Neyer U, Kronenberg F.

PLoS One. 2011;6(5):e20093. doi: 10.1371/journal.pone.0020093. Epub 2011 May 18. Review.

10.

The PTH (1-84)/non-PTH (1-84) ratio is a risk factor for cardiovascular events in hemodialysis patients.

Zitt E, Kirsch AH, Haueis M, Strasak A, Neyer U, Mayer G, Rosenkranz AR.

Clin Nephrol. 2011 Apr;75(4):309-18.

11.

The association of mid-regional pro-adrenomedullin and mid-regional pro-atrial natriuretic peptide with mortality in an incident dialysis cohort.

Gouya G, Sturm G, Lamina C, Zitt E, Freistätter O, Struck J, Wolzt M, Knoll F, Lins F, Lhotta K, Neyer U, Kronenberg F.

PLoS One. 2011 Mar 7;6(3):e17803. doi: 10.1371/journal.pone.0017803.

12.

Sex-specific association of time-varying haemoglobin values with mortality in incident dialysis patients.

Sturm G, Lamina C, Zitt E, Lhotta K, Lins F, Freistätter O, Neyer U, Kronenberg F.

Nephrol Dial Transplant. 2010 Aug;25(8):2715-22. doi: 10.1093/ndt/gfq101. Epub 2010 Feb 26.

PMID:
20190241
13.

Effect of dialysate temperature and diabetes on autonomic cardiovascular regulation during hemodialysis.

Zitt E, Neyer U, Meusburger E, Tiefenthaler M, Kotanko P, Mayer G, Rosenkranz AR.

Kidney Blood Press Res. 2008;31(4):217-25. doi: 10.1159/000141926. Epub 2008 Jun 28.

14.

Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.

Sturm G, Kollerits B, Neyer U, Ritz E, Kronenberg F; MMKD Study Group.

Exp Gerontol. 2008 Apr;43(4):347-52. doi: 10.1016/j.exger.2008.01.006. Epub 2008 Jan 26.

PMID:
18294794
15.

Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.

Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F; MMKD Study Group, Kuen E, König P, Kraatz G, Mann JF, Müller GA, Köhler H, Riegler P.

J Am Soc Nephrol. 2007 Sep;18(9):2600-8. Epub 2007 Jul 26.

16.

Cigarette smoking and chronic allograft nephropathy.

Zitt N, Kollerits B, Neyer U, Mark W, Heininger D, Mayer G, Kronenberg F, Lhotta K.

Nephrol Dial Transplant. 2007 Oct;22(10):3034-9. Epub 2007 May 21.

PMID:
17517794
17.

Prevalence of decreased glomerular filtration rate in patients seeking non-nephrological medical care--an evaluation using IDMS-traceable creatinine based MDRD as well as Mayo Clinic quadratic equation estimates.

Risch L, Saely CH, Neyer U, Hoefle G, Gouya G, Zerlauth M, Risch GM, Risch M, Drexel H.

Clin Chim Acta. 2007 Mar;378(1-2):71-7. Epub 2006 Oct 27.

PMID:
17157286
18.

Role of the kidney in the metabolism of apolipoprotein A-IV: influence of the type of proteinuria.

Lingenhel A, Lhotta K, Neyer U, Heid IM, Rantner B, Kronenberg MF, König P, von Eckardstein A, Schober M, Dieplinger H, Kronenberg F.

J Lipid Res. 2006 Sep;47(9):2071-9. Epub 2006 Jun 20.

19.

A simple score predicts future cardiovascular events in an inception cohort of dialysis patients.

Schwaiger JP, Neyer U, Sprenger-Mähr H, Kollerits B, Mündle M, Längle M, Kronenberg F.

Kidney Int. 2006 Aug;70(3):543-8. Epub 2006 Jun 14.

20.

Carotid plaques and their predictive value for cardiovascular disease and all-cause mortality in hemodialysis patients considering renal transplantation: a decade follow-up.

Schwaiger JP, Lamina C, Neyer U, König P, Kathrein H, Sturm W, Lhotta K, Gröchenig E, Dieplinger H, Kronenberg F.

Am J Kidney Dis. 2006 May;47(5):888-97.

PMID:
16632029
21.

Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study.

Boes E, Fliser D, Ritz E, König P, Lhotta K, Mann JF, Müller GA, Neyer U, Riegel W, Riegler P, Kronenberg F.

J Am Soc Nephrol. 2006 Feb;17(2):528-36. Epub 2005 Dec 28.

22.

Proteinuria and hemoglobin levels in patients with primary glomerular disease.

Mähr N, Neyer U, Prischl F, Kramar R, Mayer G, Kronenberg F, Lhotta K.

Am J Kidney Dis. 2005 Sep;46(3):424-31.

PMID:
16129203
23.

Variable parathyroid hormone(1-84)/carboxylterminal PTH ratios detected by 4 novel parathyroid hormone assays.

Koller H, Zitt E, Staudacher G, Neyer U, Mayer G, Rosenkranz AR.

Clin Nephrol. 2004 May;61(5):337-43.

PMID:
15182128
24.

Results of a nationwide screening for Anderson-Fabry disease among dialysis patients.

Kotanko P, Kramar R, Devrnja D, Paschke E, Voigtländer T, Auinger M, Pagliardini S, Spada M, Demmelbauer K, Lorenz M, Hauser AC, Kofler HJ, Lhotta K, Neyer U, Pronai W, Wallner M, Wieser C, Wiesholzer M, Zodl H, Födinger M, Sunder-Plassmann G.

J Am Soc Nephrol. 2004 May;15(5):1323-9. Erratum in: J Am Soc Nephrol. 2004 Aug;15(8):1a. J Am Soc Nephrol. 2004 Sep;15(9):A4.

25.

Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries.

Neumann HP, Salzmann M, Bohnert-Iwan B, Mannuelian T, Skerka C, Lenk D, Bender BU, Cybulla M, Riegler P, Königsrainer A, Neyer U, Bock A, Widmer U, Male DA, Franke G, Zipfel PF.

J Med Genet. 2003 Sep;40(9):676-81.

26.

Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin.

Weiss G, Meusburger E, Radacher G, Garimorth K, Neyer U, Mayer G.

Kidney Int. 2003 Aug;64(2):572-8.

27.

Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients.

Kronenberg F, Lingenhel A, Neyer U, Lhotta K, König P, Auinger M, Wiesholzer M, Andersson H, Dieplinger H.

Kidney Int Suppl. 2003 May;(84):S113-6.

PMID:
12694323
28.

Prevalence and progression of peripheral arterial calcifications in patients with ESRD.

Kronenberg F, Mündle M, Längle M, Neyer U.

Am J Kidney Dis. 2003 Jan;41(1):140-8.

PMID:
12500231
29.

Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study.

Haas M, Mayer G, Wirnsberger G, Holzer H, Ratschek M, Neyer U, Neuweiler J, Kramar R, Schneider B, Breiteneder-Geleff S, Regele HM, Hörl WH, Kerjaschki D.

Wien Klin Wochenschr. 2002 Feb 28;114(4):143-7.

PMID:
12060980
30.

Total parathyroidectomy with autotransplantation in renal hyperparathyroidism: low recurrence after intra-operative tissue selection.

Neyer U, Hoerandner H, Haid A, Zimmermann G, Niederle B.

Nephrol Dial Transplant. 2002 Apr;17(4):625-9.

PMID:
11917056
31.

Apolipoprotein A-IV serum concentrations are elevated in patients with mild and moderate renal failure.

Kronenberg F, Kuen E, Ritz E, König P, Kraatz G, Lhotta K, Mann JF, Müller GA, Neyer U, Riegel W, Riegler P, Schwenger V, von Eckardstein A.

J Am Soc Nephrol. 2002 Feb;13(2):461-9.

32.

Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate.

Bostom AG, Kronenberg F, Jacques PF, Kuen E, Ritz E, König P, Kraatz G, Lhotta K, Mann JF, Müller GA, Neyer U, Riegel W, Schwenger V, Riegler P, Selhub J.

Atherosclerosis. 2001 Nov;159(1):219-23.

PMID:
11689224
33.

Chronic renal transplantation: a model for the hyperhomocysteinemia of renal insufficiency.

Bostom AG, Kronenberg F, Gohh RY, Schwenger V, Kuen E, König P, Kraatz G, Lhotta K, Mann JF, Müller GA, Neyer U, Riegel W, Riegler P, Ritz E, Selhub J.

Atherosclerosis. 2001 May;156(1):227-30.

PMID:
11369018
34.

[Focal proliferation in reactive hyperplastic parathyroid tissue in end-stage renal failure--implication for autotransplantation after total parathyroidectomy].

Hörandner H, Mürzl E, Neyer U, Breiteneder-Geleff S, Niederle B, Haid A, Breitfellner G.

Wien Klin Wochenschr. 2000 Apr 21;112(8):353-7. German.

PMID:
10849940
35.

Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure.

Kronenberg F, Kuen E, Ritz E, Junker R, König P, Kraatz G, Lhotta K, Mann JF, Müller GA, Neyer U, Riegel W, Reigler P, Schwenger V, Von Eckardstein A.

J Am Soc Nephrol. 2000 Jan;11(1):105-15.

36.

[Leptospirosis (Weil's syndrome) with renal failure, severe jaundice, disseminated hemorrhages and xanthopsia].

Fuchs W, Wolber T, Wöss E, Neyer U, Drexel H.

Schweiz Med Wochenschr. 1999 Jun 5;129(22):847-50. German.

PMID:
10413823
37.

Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up.

Kerschdorfer L, König P, Neyer U, Bösmüller C, Lhotta K, Auinger M, Hohenegger M, Riegler P, Margreiter R, Utermann G, Dieplinger H, Kronenberg F.

Atherosclerosis. 1999 Jun;144(2):381-91.

PMID:
10407499
38.

[Intraoperative blood sampling for parathyroid hormone measurement during total parathyroidectomy and autotransplantation in patients with renal hyperparathyroidism].

Koeberle-Wuehrer R, Haid A, Sprenger-Maehr H, Koeberle D, Meusburger E, Neyer U.

Wien Klin Wochenschr. 1999 Mar 26;111(6):246-50. German.

PMID:
10234780
39.

The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: a prospective follow-up.

Kronenberg F, Neyer U, Lhotta K, Trenkwalder E, Auinger M, Pribasnig A, Meisl T, König P, Dieplinger H.

J Am Soc Nephrol. 1999 May;10(5):1027-36.

40.
41.

LDL-unbound apolipoprotein(a) and carotid atherosclerosis in hemodialysis patients.

Kronenberg F, Trenkwalder E, Sturm W, Kathrein H, König P, Neyer U, Gröchenig E, Utermann G, Dieplinger H.

Clin Genet. 1997 Nov;52(5):377-86.

PMID:
9520130
42.

Effect of cyclosporin A in a patient with refractory nephrotic syndrome associated with B chronic lymphocytic leukemia.

Eisterer W, Neyer U, Hilbe W, Diem G, Ohlschlegel C, Ludescher C, Thaler J.

Nephron. 1996;72(3):468-71.

PMID:
8852499
43.

Influence of various heparin preparations on lipoproteins in hemodialysis patients: a multicentre study.

Kronenberg F, König P, Neyer U, Auinger M, Pribasnig A, Meisl T, Pinter G, Dieplinger H.

Thromb Haemost. 1995 Oct;74(4):1025-8.

PMID:
8560405
44.

MR imaging in graft-dependent recurrent hyperparathyroidism after parathyroidectomy and autotransplantation.

Hergan K, Neyer U, Doringer W, Mündle M.

J Magn Reson Imaging. 1995 Sep-Oct;5(5):541-4.

PMID:
8574038
45.

Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.

Kronenberg F, König P, Neyer U, Auinger M, Pribasnig A, Lang U, Reitinger J, Pinter G, Utermann G, Dieplinger H.

J Am Soc Nephrol. 1995 Jul;6(1):110-20.

46.

Alpha 1-antitrypsin phenotypes in patients with anti-neutrophil cytoplasmic antibody-positive vasculitis.

Lhotta K, Vogel W, Meisl T, Buxbaum M, Neyer U, Sandholzer C, König P.

Clin Sci (Lond). 1994 Dec;87(6):693-5.

PMID:
7874861
47.

Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease.

Kronenberg F, Kathrein H, König P, Neyer U, Sturm W, Lhotta K, Gröchenig E, Utermann G, Dieplinger H.

Arterioscler Thromb. 1994 Sep;14(9):1405-11.

PMID:
8068600
48.

Interferon treatment for chronic hepatitis C virus infection in uremic patients.

Koenig P, Vogel W, Umlauft F, Weyrer K, Prommegger R, Lhotta K, Neyer U, Stummvoll HK, Gruenewald K.

Kidney Int. 1994 May;45(5):1507-9. No abstract available.

49.

Wegener's granulomatosis associated with silicosis.

Neyer U, Wöss E, Neuweiler J.

Nephrol Dial Transplant. 1994;9(5):559-61. No abstract available.

PMID:
8090339
50.

[Low dosage intravenous calcitriol bolus therapy in chronic hemodialysis patients].

Neyer U, Wöss E, Drexel H.

Acta Med Austriaca. 1994;21(5):129-32. German.

PMID:
7709710

Supplemental Content

Support Center